TrialJournal of neuromuscular diseases2021

A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD Trial.

Richard S Finkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.